1、信臣健康
创始人：王鑫
项目名称：喜芽听诊式智能胎儿监护系统
项目单位：江苏信臣健康科技股份有限公司
项目简介：创始人王鑫，苏州大学临床医学学士，中国人民大学国际经济研究生，南京大学EMBA，早期从事儿童出生缺陷、自闭症等研究。信臣健康致力于提供先进的孕产期人工智能产品和专业的健康管理解决方案，现已发展成为集产品研发、生产、市场推广和销售为一体的综合性高科技企业。公司主打产品--喜芽，作为全球唯一通过医疗器械认证的听诊式胎儿监护设备及系统,具有安全性高、数据全面、结果精准、AI智能评分等优势。能够轻松实现从院内到院外的全方位、一体化胎儿监护，准确掌握胎儿宫内状态,及时预警早产及宫内缺氧，保障母婴安全。公司以听诊式胎心监测技术为基础，逐渐发展为基于智能硬件的母婴健康数据服务商。
1、Jiangsu Shinsson Health Technology Co., Ltd.
Founder: Xin Wang
Project Name: Intelligent PCG fetal monitoring system (Fetaphon)
Company Name: Jiangsu Shinsson Health Technology Co., Ltd.
Introduction：Mr. Xin Wang, the founder of Shinsson Health, graduated from Medical School of Soochow University and later obtained his postgraduate degree in International Economy in Renmin University of China and EMBA degree in Nanjing University. He served as a psychiatrist studying on mental defects and autism in children in his early years.
Shinsson Health is dedicated to developing advanced AI products and professional health management solutions for maternal healthcare. Now the company has evolved into a high-tech enterprise integrating R&D, manufacturing, marketing and distribution.
As the flagship product, Fetaphon is the only NMPA-cleared PCG fetal monitoring device/system with highly safe design, comprehensive monitoring data, precise results and AI intelligent scoring.
By monitoring the fetal status and early warning to pre-term birth and intrauterine hypoxia, the product provides all around fetal monitoring service in/out of hospitals to ensure the safety of moms and babies.
Based on the PCG fetal heart monitoring technology, the company aims to be service provider of health data relying on intelligent devices in the future.
2、Nreal
联合创始人：徐驰博士
项目名称：AR/MR（增强与混合现实）智能应用
项目公司：深圳太若科技有限公司（Nreal）
项目简介：联合创始人徐驰博士，浙江大学毕业后留学美国明尼苏达大学，曾在Magic Leap任资深研发工程师，2017年1月回国创业，聚焦AR（增强现实）、MR（混合现实）眼镜整机设计、 研发、生产、销售及相关场景应用研究。公司已经累计融资约2亿元人民币，历史投资人包括 顺为、鸿泰、新松、华创、爱奇艺、光大控股、华进资本、广州开发区产业基金集团等知名投资者。
2、Nreal
Co-founder：Dr. Xu Chi
Project Name：AR/MR (Augmented and Mixed Reality) Smart Applications
Company Name：Nreal Limited
Introduction：Dr. Xu Chi, co-founder of Nreal, studied at the University of Minnesota after graduating from Zhejiang University and once worked as a senior R&D engineer at Magic Leap. He returned to China in January 2017 to establish his venture, focusing on integrated design, R&D, production, sales and research of use scenarios for AR (augmented reality) and MR (mixed reality) glasses. The company has raised approximately 200 million RMB in funding, with investors including Shunwei, Hongtai, Xinsong, Huachuang, iQiyi, Everbright, Huajin Capital, Guangzhou Development Zone Industrial Fund Group and other well-known investors.
3、南京沿溯大数据
联合创始人：杨仑博士
项目名称：爱数智药平台及其在创造First-in-Class药物中的应用
项目公司：南京沿溯大数据有限公司
项目简介：联合创始人杨仑博士，上海交通大学毕业，曾任职拜耳（德国）全球研发副总监、葛兰素史克（美国）R&D高级科学家，上海交大Bio-X兼职教授，2019年从欧洲（德国）回家乡南京创业。爱数智耀™是一家致力于通过医药大数据和机器学习助力全球药企及其服务商加速解决未被满足的医学需求的高科技创新公司。公司致力于打造全球首个基于AI的first-in-class药物研发、交易、转化平台。核心团队由来自全球知名药企的医药研发专家和顶尖互联网企业的大数据及深度学习专家组成，致力于将专业知识的深度和跨学科协作结合起来，在整个药物发研发过程中产生协同效应。
爱数智耀™深度学习平台是一个领先的大数据和机器学习平台，该平台可以用于寻找治疗疾病的新方法，并为患者提供个性化药物。爱数智耀™学习平台专注于first-in-class药物研发过程，包括：知识和推理、目标识别、假说优化和精确医学。
3、Nanjing Yesu Big Data
Co-founder：Dr. Yang Lun
Project Name：An AI-based platform (AIdPharma) and its application in discovering first-in-class pharmaceuticals
Company Name：Nanjing Yesu Big Data
Introduction：Dr. Yang Lun, co-founder of AIDPharma, graduated from Shanghai Jiao Tong University, previously Deputy Director of Global R&D, Bayer Pharmaceuticals (Germany), Senior R&D Scientist of GlaxoSmithKline (USA), Adjunct Professor at Bio-X center of SJTU. He came back to Nanjing from Germany to establish his venture. AIDPharma is a high-tech innovation company dedicated to use medical big data and machine learning to accelerate global pharmaceutical companies and their service providers to address unmet needs. The company is committed to building the world's first AI-based first-in-class drug development, trade and translation platform. The core team consists of R&D experts from the world's leading pharmaceutical companies and big data and deep learning experts from top internet companies. They are dedicated to combining deep vertical expertise with interdisciplinary collaboration to create synergies throughout the drug development process.
AIDPharma is a leading big data and machine learning platform that can be used to find new ways to treat diseases and provide personalized medicine for patients. It focuses on the first-in-class drug development process, including: knowledge building and reasoning, target identification, hypothesis optimization and precision medicine.
4、STEMEASY
联合创始人：陈慧敏博士
项目名称：生物3D打印
项目公司：江阴司特易生物技术有限公司
项目简介：联合创始人陈慧敏博士，北京大学运动医学博士，美国哈佛大学医学院博士后及讲师，后任职美国惠氏制药资深科学家、GSK中国研发管理负责人。司特易主要从事干细胞及生物3D打印技术相关产品的研发和应用。公司以源于哈佛大学的干细胞技术为核心，技术团队全面掌握了干细胞的提取、纯化、扩增和分化等干细胞技术。2018年SE在上海成立全资子公司__华夏司印（SinoBioPrint，SBP），专注生物3D打印技术，自研自产蓝光光敏天然生物3D打印材料（生物墨水）十多种，在纯度、种类、生物相容性和光固化效率上均达到国际先进水平。结合两公司的两个平台技术，五年来开展了多个软骨3D打印技术的临床转化：1）生物3D打印枪；2）软骨再生水凝胶；3）骨软骨3D打印支架；4）耳软骨3D打印；5）髋关节软骨内衬3D打印。
4、STEMEASY
Co-founder：Dr. Chen Huimin
Project Name：Bio 3D printing
Company Name：Stemeasy
Introduction：Dr. Chen Huimin, co-founder, PhD in Sports Medicine from Peking University and a postdoctoral fellow and lecturer at Harvard Medical School, previously a senior scientist at Wyeth Pharmaceuticals and head of R&D management at GSK China. Stemeasy focuses on development and application of stem cells and bio 3D printing technology and products. The company leverages the stem cell technology from Harvard University. Its technical team fully masters the stem cell extraction, purification, amplification and differentiation technology. In 2018, Stemeasy established SinoBioPrint (SBP), a wholly owned subsidiary in Shanghai, that specializes in bio 3D printing technology, and focuses on developing and producing independently its own blue light-sensitive natural 3D printing materials (bio-ink). It can produce up to a dozen types of these bio-ink, all reaching internationally advanced level in purity, variety, biocompatibility and light curing efficiency. By combining technologies from the platforms of the two companies, it has successfully applied cartilage 3D printing clinically multiple times in the past five years. Specifically, it consists technologies of 1) a bio 3D printing gun; 2) cartilage regenerative hydrogels; 3) osteochondral 3D printed scaffolds; 4) ear cartilage 3D printing; and 5) hip cartilage Inset 3D Printing.
5、南航精密驱动与控制研究所
联合创始人：吴大伟博士
项目名称：医学超声换能器技术及其应用
项目单位：南京航空航天大学精密驱动与控制研究所
项目简介：医学超声技术具有安全、无创、便捷、穿透力强等优点，包括聚焦超声治疗在内的无创精准治疗是未来医疗发展的大趋势。项目团队掌握聚焦超声无创精准治疗共性关键技术，已经研发出高强度聚焦超声肿瘤治疗系统样机，其在子宫肌瘤和胰腺癌等疾病的无创治疗中具有重要临床价值。目前项目团队正在研发适用症更多、适用人群更多的超声聚焦止痛仪以及目前处于临床转化关键时机的低强度聚焦超声脑刺激系统。
5、Precision Drive and Control Institute, Nanjing University of Aeronautics and Astronautics
Co-founder：Dr. Wu Dawei
Project Name：Medical Ultrasound Technology and Its Application
Company Name：Precision Drive and Control Institute, Nanjing University of Aeronautics and Astronautics
Introduction:Medical ultrasound is safe, non-invasive, convenient and strong. Noninvasive precision therapy including focused ultrasound therapy represents the main trend of precision medicine. Our team has fully mastered the key technologies of focused ultrasound non-invasive precise treatments, and has developed a prototype of high-intensity focused ultrasound tumor treatment system, which has important clinical value in the non-invasive treatment of myoma of uterus, pancreatic cancer and other diseases. At present, the team is developing a focused ultrasound pain-relieving technology that can be applied in more patients and diseases, and a low-intensity focused ultrasound brain stimulation system which is currently at the critical stage of clinical transformation.
6、科甄-中研在线
联合创始人：束兰根博士
项目名称：科甄-中研在线
项目单位：上海科甄信息科技有限公司
项目简介：联合联合创始人束兰根博士，南京大学工程管理学院毕业，曾任交通银行江苏省分行副行长、交通银行苏州分行行长、国家开发银行江苏省分行副行长等。科技金融、绿色金融专家，出版《科技金融理论与实践》、《科技金融创新与发展》、《绿色金融解释》、《绿色金融基础读本》等专著。
科甄-中研在线，全球技术经纪与产业投资云平台，由百位知名科学家、技术杰青、科技投资人、企业家联合发起，上海科甄信息科技有限公司负责营运。通过技术经纪人对科技投资、技术成果转化进行专业管理，用技术图谱与产融地图智甄科技创新项目，用联合实验室与智约耘链系统实现全球资源协同创新，让科OO专注创新与产品，让政、产、学、研、金、介、宣，与科OO放心共舞！
6、Kezhen-Sino Global Tech Investment Platform
Co-founder：Dr. Shu Langen
Project Name：Kezhen-Sino Global Tech Investment Platform
Company Name：Shanghai Kezhen Information Technology
Introduction：
Co-founded by Dr. Shu Langen, graduated from Nanjing University School of Engineering and Management, previously Vice President of Bank of Communications Jiangsu Branch and President of Bank of Communications Suzhou Branch, Vice President of China Development Bank Jiangsu Branch. He is an expert in fin-tech and green finance, and has published books like “Theory and Practice of Fin-tech”, “Innovation and Development of Fin-tech”, and “Explaining Green Finance” and “Basic Readings of Green Finance”.
Kezhen-Sino Global Tech Investment Platform is a global tech brokerage and investment cloud platform, comprised of hundreds of famous scientists, young technology experts, tech investors and entrepreneurs. It’s operated by Shanghai Kezhen Information Technology Company Limited. Basically, coordinated global innovation is enabled through professional management of tech investments and achievements by tech brokers, use of tech, industry and financial maps in Kezhen’s tech innovation project pools, and use of joint labs and a smart linkage system. In this way, researchers could focus on innovation and product development, while governments, industries, universities, academia, brokerages and promotors can work with tech experts with confidence!
7、CENTI Group
联合创始人：宰承锋
项目简介：China-Europe Networks of Technology and Innovation Limited（简称：CENTI），中文名：中欧科技创新网络，注册于英国伦敦市，聚焦中国与欧洲之间的技术、产业、经济和金融等合作机会，以国际化拓展为导向，为欧洲企业提供中国市场融资及战略咨询服务，也为中国企业寻求国际合作伙伴及前沿科学技术并落地中国。
CENTI Group依托其在中国和欧洲多年来拓展的广阔合作网络，致力于打造中欧之间专注于技术转化、产融结合、创新和国际化等中欧企业核心诉求的跨境生态圈。
CENTI Group设有欧洲双总部，分别位于欧洲的伦敦及欧盟的布鲁塞尔且在瑞典拥有一处合作运营空间，覆盖西欧及北欧各国；同时在中国上海设有中国总部，全称为上海阔控汉殿商务咨询有限公司（简称：上海阔控），上海阔控是CENTI Group在境内的平行公司，实际控制人为同一人，并统一使用CENTI Group及中欧科技创新网络作为公司品牌名称，实现全方位的跨境协同。
Co-founder：JOHN ZAI
Company Name：CENTI Group
Introduction：China-Europe Networks of Technology and Innovation Limited (CENTI Group) is registered in the City of London, and focuses on technology, industry, economic and financial cooperation opportunities between China and Europe. CENTI is guided by internationalization, provides Financing and Strategic Advisory Services to European enterprises in the Chinese market, and seeks international partners and cutting-edge science and technology for Chinese companies to land in China.
Based on its extensive network of cooperation in China and Europe over the years, CENTI Group is committed to building a cross-border ecosystem between China and Europe that focuses on the core demands of China-EU enterprises, such as technology transformation, production and integration, innovation and internationalization.
CENTI Group has dual European headquarters in London and Brussels, and has a co-operation space in Sweden covering Western and Northern European countries. At the same, CENTI has its headquarter in Shanghai, which is known as Shanghai Kuo Kong Han Dian Business Consulting Co., Ltd. It is a parallel company of CENTI Group in the territory with the actual control of the same person, and the unified use of CENTI Group as the company‘s brand name to achieve a full range of cross-border synergies.
8、Poligy
联合创始人：Artur Steffe
项目名称：新材料实现低温余热发电
项目简介：该公司正在开发一种可持续的解决方案，利用获得专利的废热回收双聚物系统将低级废热转化为电能。与其他解决方案相比，这项革命性技术在50 – 150ºC的温度范围内将废热转化为电能的效率可以达到4％– 15％，而成本却相对较低。
双聚物的功能类似于双金属。双金属片由两条压在一起的不同金属带组成，由于它们的线性膨胀系数不同，它们在加热下会发生不同的膨胀。当具有较高系数的金属比具有较低系数的金属膨胀更大时，轧制带就会发生弯曲。二元共聚物的作用原理完全相同，只是由两种聚合物压制组成。由于聚合物可以具有更大和更小的线性膨胀系数，因此弯曲的效果也更强。
Co-founder：Artur Steffe
Project Name：Waste Heat Game-Changer
Company Name：Poligy
Introduction：
The company is developing a sustainable solution that turns low-grade waste heat into electricity with the patented Waste Heat Recovery Bipolymer System. This revolutionary technology can achieve 4% – 15% conversion efficiency of waste heat into electricity within the temperature range of 50 – 150 ºC with relatively lower costs compared to other solutions.
Bipolymers function similarly to bimetals. Bimetals consist of two strips of different metals pressed together, which, thanks to their different coefficients of linear expansion, expand differently under heat. As the metal with the higher coefficient expands more than the metal with the lower coefficient, the rolled strip bends. Bipolymers function according to exactly the same principle, but consist of two polymers pressed together. Since polymers can have both much larger and much smaller coefficients of linear expansion, the effect of bending is also much stronger.
